Extra-perigastric Extranodal Metastasis is a Significant Prognostic Factor in Node-Positive Gastric Cancer

Background Extranodal metastasis is an isolated tumor nodule without a residual lymph node structure and has been reported as a poor prognostic factor in gastric cancer. The aim of this study is to assess the prognostic value of extranodal metastasis, especially from the viewpoint of its anatomical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of surgery 2019-10, Vol.43 (10), p.2499-2505
Hauptverfasser: Tonouchi, Akiko, Sugano, Masato, Tokunaga, Masanori, Sugita, Shizuki, Watanabe, Masahiro, Sato, Reo, Kaito, Akio, Akimoto, Tetsuo, Ochiai, Atsushi, Kinoshita, Takahiro, Kuwata, Takeshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2505
container_issue 10
container_start_page 2499
container_title World journal of surgery
container_volume 43
creator Tonouchi, Akiko
Sugano, Masato
Tokunaga, Masanori
Sugita, Shizuki
Watanabe, Masahiro
Sato, Reo
Kaito, Akio
Akimoto, Tetsuo
Ochiai, Atsushi
Kinoshita, Takahiro
Kuwata, Takeshi
description Background Extranodal metastasis is an isolated tumor nodule without a residual lymph node structure and has been reported as a poor prognostic factor in gastric cancer. The aim of this study is to assess the prognostic value of extranodal metastasis, especially from the viewpoint of its anatomical distribution. Methods A total of 139 consecutive gastric cancer patients who underwent curative surgery with lymph node metastasis between 2008 and 2009 were included. Clinicopathological features and patient survival outcomes were retrospectively assessed. Patients with extranodal metastasis were subdivided into two groups: perigastric extranodal metastasis, located near the perigastric area (#1–#7 according to the Japanese classification of gastric carcinoma 15th edition), and extra-perigastric extranodal metastasis, located alongside the major vessels (#8–#12). Results Extranodal metastasis was found in 51 patients (37%), and it was more frequent in those with bulky, ≥pT3, and pStage III tumors. All patients with extra-perigastric extranodal metastasis had recurrence, resulting in a 0% 5-year overall survival rate, which was significantly worse than that of patients with perigastric extranodal metastasis (59%), or those without extranodal metastasis (84%; P  
doi_str_mv 10.1007/s00268-019-05076-x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2258474187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2258474187</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5654-8c8c0e17f0e2dbbc1e9e731aa282e9904ac5003a408ac499cbf28606ff6467373</originalsourceid><addsrcrecordid>eNqNkEtLAzEUhYMotj7-gAsZcB29ecxkxp2WtipVC1VchkyaKSl1UpOp1n9vdKruRAgkHM537s1B6IjAKQEQZwGAZjkGUmBIQWR4vYW6hDOKKaNsG3WBZTy-CeugvRDmAERkkO2iTpQILbjoonl_3XiFl8bbmQqNtzr5Umo3VYvk1jRRVMGGJB6VTOystpXVqm6SsXez2oUmEgOlG-cTWyd3bmrw2AXb2FeTDDeJPVVr4w_QTqUWwRxu7n30OOg_9K7w6H543bsYYZ1mKce5zjUYIiowdFqWmpjCCEaUojk1RQFc6RSAKQ650rwodFnRPH6rqjKeCSbYPjppc5fevaxMaOTcrXwdR0pK05wLTvJPF21d2rsQvKnk0ttn5d8lAflZr2zrlbFe-VWvXEfoeBO9Kp_N9Af57jMazlvDm12Y939EyqebyeUAAAoeYdbCIXL1zPjfxf_Y6QNJQ5f0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2258474187</pqid></control><display><type>article</type><title>Extra-perigastric Extranodal Metastasis is a Significant Prognostic Factor in Node-Positive Gastric Cancer</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>SpringerLink Journals</source><creator>Tonouchi, Akiko ; Sugano, Masato ; Tokunaga, Masanori ; Sugita, Shizuki ; Watanabe, Masahiro ; Sato, Reo ; Kaito, Akio ; Akimoto, Tetsuo ; Ochiai, Atsushi ; Kinoshita, Takahiro ; Kuwata, Takeshi</creator><creatorcontrib>Tonouchi, Akiko ; Sugano, Masato ; Tokunaga, Masanori ; Sugita, Shizuki ; Watanabe, Masahiro ; Sato, Reo ; Kaito, Akio ; Akimoto, Tetsuo ; Ochiai, Atsushi ; Kinoshita, Takahiro ; Kuwata, Takeshi</creatorcontrib><description>Background Extranodal metastasis is an isolated tumor nodule without a residual lymph node structure and has been reported as a poor prognostic factor in gastric cancer. The aim of this study is to assess the prognostic value of extranodal metastasis, especially from the viewpoint of its anatomical distribution. Methods A total of 139 consecutive gastric cancer patients who underwent curative surgery with lymph node metastasis between 2008 and 2009 were included. Clinicopathological features and patient survival outcomes were retrospectively assessed. Patients with extranodal metastasis were subdivided into two groups: perigastric extranodal metastasis, located near the perigastric area (#1–#7 according to the Japanese classification of gastric carcinoma 15th edition), and extra-perigastric extranodal metastasis, located alongside the major vessels (#8–#12). Results Extranodal metastasis was found in 51 patients (37%), and it was more frequent in those with bulky, ≥pT3, and pStage III tumors. All patients with extra-perigastric extranodal metastasis had recurrence, resulting in a 0% 5-year overall survival rate, which was significantly worse than that of patients with perigastric extranodal metastasis (59%), or those without extranodal metastasis (84%; P  &lt; 0.001). Multivariable analysis identified the presence of extra-perigastric extranodal metastasis as an independent poor prognostic factor. Conclusions Extranodal metastasis, especially extra-perigastric extranodal metastasis, was a pivotal poor prognostic factor in node-positive gastric cancer. Recognizing extra-perigastric extranodal metastasis would help provide optimal therapeutic options to these high-risk patients.</description><identifier>ISSN: 0364-2313</identifier><identifier>EISSN: 1432-2323</identifier><identifier>DOI: 10.1007/s00268-019-05076-x</identifier><identifier>PMID: 31312947</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Abdominal Surgery ; Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; Blood vessels ; Cancer ; Cardiac Surgery ; Female ; Gastrectomy ; Gastric cancer ; General Surgery ; Humans ; Kaplan-Meier Estimate ; Lymph nodes ; Lymph Nodes - pathology ; Lymphatic Metastasis ; Lymphatic system ; Male ; Medicine ; Medicine &amp; Public Health ; Metastases ; Metastasis ; Middle Aged ; Multivariate Analysis ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local - mortality ; Nodes ; Original Scientific Report ; Prognosis ; Recurrence ; Retrospective Studies ; Risk groups ; Stomach Neoplasms - mortality ; Stomach Neoplasms - pathology ; Stomach Neoplasms - surgery ; Surgery ; Survival ; Survival Rate ; Thoracic Surgery ; Treatment Outcome ; Tumors ; Vascular Surgery</subject><ispartof>World journal of surgery, 2019-10, Vol.43 (10), p.2499-2505</ispartof><rights>Société Internationale de Chirurgie 2019</rights><rights>2019 The Author(s) under exclusive licence to Société Internationale de Chirurgie</rights><rights>World Journal of Surgery is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5654-8c8c0e17f0e2dbbc1e9e731aa282e9904ac5003a408ac499cbf28606ff6467373</citedby><cites>FETCH-LOGICAL-c5654-8c8c0e17f0e2dbbc1e9e731aa282e9904ac5003a408ac499cbf28606ff6467373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00268-019-05076-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00268-019-05076-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,41464,42533,45550,45551,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31312947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tonouchi, Akiko</creatorcontrib><creatorcontrib>Sugano, Masato</creatorcontrib><creatorcontrib>Tokunaga, Masanori</creatorcontrib><creatorcontrib>Sugita, Shizuki</creatorcontrib><creatorcontrib>Watanabe, Masahiro</creatorcontrib><creatorcontrib>Sato, Reo</creatorcontrib><creatorcontrib>Kaito, Akio</creatorcontrib><creatorcontrib>Akimoto, Tetsuo</creatorcontrib><creatorcontrib>Ochiai, Atsushi</creatorcontrib><creatorcontrib>Kinoshita, Takahiro</creatorcontrib><creatorcontrib>Kuwata, Takeshi</creatorcontrib><title>Extra-perigastric Extranodal Metastasis is a Significant Prognostic Factor in Node-Positive Gastric Cancer</title><title>World journal of surgery</title><addtitle>World J Surg</addtitle><addtitle>World J Surg</addtitle><description>Background Extranodal metastasis is an isolated tumor nodule without a residual lymph node structure and has been reported as a poor prognostic factor in gastric cancer. The aim of this study is to assess the prognostic value of extranodal metastasis, especially from the viewpoint of its anatomical distribution. Methods A total of 139 consecutive gastric cancer patients who underwent curative surgery with lymph node metastasis between 2008 and 2009 were included. Clinicopathological features and patient survival outcomes were retrospectively assessed. Patients with extranodal metastasis were subdivided into two groups: perigastric extranodal metastasis, located near the perigastric area (#1–#7 according to the Japanese classification of gastric carcinoma 15th edition), and extra-perigastric extranodal metastasis, located alongside the major vessels (#8–#12). Results Extranodal metastasis was found in 51 patients (37%), and it was more frequent in those with bulky, ≥pT3, and pStage III tumors. All patients with extra-perigastric extranodal metastasis had recurrence, resulting in a 0% 5-year overall survival rate, which was significantly worse than that of patients with perigastric extranodal metastasis (59%), or those without extranodal metastasis (84%; P  &lt; 0.001). Multivariable analysis identified the presence of extra-perigastric extranodal metastasis as an independent poor prognostic factor. Conclusions Extranodal metastasis, especially extra-perigastric extranodal metastasis, was a pivotal poor prognostic factor in node-positive gastric cancer. Recognizing extra-perigastric extranodal metastasis would help provide optimal therapeutic options to these high-risk patients.</description><subject>Abdominal Surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis of Variance</subject><subject>Blood vessels</subject><subject>Cancer</subject><subject>Cardiac Surgery</subject><subject>Female</subject><subject>Gastrectomy</subject><subject>Gastric cancer</subject><subject>General Surgery</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Lymph nodes</subject><subject>Lymph Nodes - pathology</subject><subject>Lymphatic Metastasis</subject><subject>Lymphatic system</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Nodes</subject><subject>Original Scientific Report</subject><subject>Prognosis</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>Risk groups</subject><subject>Stomach Neoplasms - mortality</subject><subject>Stomach Neoplasms - pathology</subject><subject>Stomach Neoplasms - surgery</subject><subject>Surgery</subject><subject>Survival</subject><subject>Survival Rate</subject><subject>Thoracic Surgery</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><subject>Vascular Surgery</subject><issn>0364-2313</issn><issn>1432-2323</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkEtLAzEUhYMotj7-gAsZcB29ecxkxp2WtipVC1VchkyaKSl1UpOp1n9vdKruRAgkHM537s1B6IjAKQEQZwGAZjkGUmBIQWR4vYW6hDOKKaNsG3WBZTy-CeugvRDmAERkkO2iTpQILbjoonl_3XiFl8bbmQqNtzr5Umo3VYvk1jRRVMGGJB6VTOystpXVqm6SsXez2oUmEgOlG-cTWyd3bmrw2AXb2FeTDDeJPVVr4w_QTqUWwRxu7n30OOg_9K7w6H543bsYYZ1mKce5zjUYIiowdFqWmpjCCEaUojk1RQFc6RSAKQ650rwodFnRPH6rqjKeCSbYPjppc5fevaxMaOTcrXwdR0pK05wLTvJPF21d2rsQvKnk0ttn5d8lAflZr2zrlbFe-VWvXEfoeBO9Kp_N9Af57jMazlvDm12Y939EyqebyeUAAAoeYdbCIXL1zPjfxf_Y6QNJQ5f0</recordid><startdate>20191015</startdate><enddate>20191015</enddate><creator>Tonouchi, Akiko</creator><creator>Sugano, Masato</creator><creator>Tokunaga, Masanori</creator><creator>Sugita, Shizuki</creator><creator>Watanabe, Masahiro</creator><creator>Sato, Reo</creator><creator>Kaito, Akio</creator><creator>Akimoto, Tetsuo</creator><creator>Ochiai, Atsushi</creator><creator>Kinoshita, Takahiro</creator><creator>Kuwata, Takeshi</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20191015</creationdate><title>Extra-perigastric Extranodal Metastasis is a Significant Prognostic Factor in Node-Positive Gastric Cancer</title><author>Tonouchi, Akiko ; Sugano, Masato ; Tokunaga, Masanori ; Sugita, Shizuki ; Watanabe, Masahiro ; Sato, Reo ; Kaito, Akio ; Akimoto, Tetsuo ; Ochiai, Atsushi ; Kinoshita, Takahiro ; Kuwata, Takeshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5654-8c8c0e17f0e2dbbc1e9e731aa282e9904ac5003a408ac499cbf28606ff6467373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Abdominal Surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis of Variance</topic><topic>Blood vessels</topic><topic>Cancer</topic><topic>Cardiac Surgery</topic><topic>Female</topic><topic>Gastrectomy</topic><topic>Gastric cancer</topic><topic>General Surgery</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Lymph nodes</topic><topic>Lymph Nodes - pathology</topic><topic>Lymphatic Metastasis</topic><topic>Lymphatic system</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Nodes</topic><topic>Original Scientific Report</topic><topic>Prognosis</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>Risk groups</topic><topic>Stomach Neoplasms - mortality</topic><topic>Stomach Neoplasms - pathology</topic><topic>Stomach Neoplasms - surgery</topic><topic>Surgery</topic><topic>Survival</topic><topic>Survival Rate</topic><topic>Thoracic Surgery</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><topic>Vascular Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tonouchi, Akiko</creatorcontrib><creatorcontrib>Sugano, Masato</creatorcontrib><creatorcontrib>Tokunaga, Masanori</creatorcontrib><creatorcontrib>Sugita, Shizuki</creatorcontrib><creatorcontrib>Watanabe, Masahiro</creatorcontrib><creatorcontrib>Sato, Reo</creatorcontrib><creatorcontrib>Kaito, Akio</creatorcontrib><creatorcontrib>Akimoto, Tetsuo</creatorcontrib><creatorcontrib>Ochiai, Atsushi</creatorcontrib><creatorcontrib>Kinoshita, Takahiro</creatorcontrib><creatorcontrib>Kuwata, Takeshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>World journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tonouchi, Akiko</au><au>Sugano, Masato</au><au>Tokunaga, Masanori</au><au>Sugita, Shizuki</au><au>Watanabe, Masahiro</au><au>Sato, Reo</au><au>Kaito, Akio</au><au>Akimoto, Tetsuo</au><au>Ochiai, Atsushi</au><au>Kinoshita, Takahiro</au><au>Kuwata, Takeshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extra-perigastric Extranodal Metastasis is a Significant Prognostic Factor in Node-Positive Gastric Cancer</atitle><jtitle>World journal of surgery</jtitle><stitle>World J Surg</stitle><addtitle>World J Surg</addtitle><date>2019-10-15</date><risdate>2019</risdate><volume>43</volume><issue>10</issue><spage>2499</spage><epage>2505</epage><pages>2499-2505</pages><issn>0364-2313</issn><eissn>1432-2323</eissn><abstract>Background Extranodal metastasis is an isolated tumor nodule without a residual lymph node structure and has been reported as a poor prognostic factor in gastric cancer. The aim of this study is to assess the prognostic value of extranodal metastasis, especially from the viewpoint of its anatomical distribution. Methods A total of 139 consecutive gastric cancer patients who underwent curative surgery with lymph node metastasis between 2008 and 2009 were included. Clinicopathological features and patient survival outcomes were retrospectively assessed. Patients with extranodal metastasis were subdivided into two groups: perigastric extranodal metastasis, located near the perigastric area (#1–#7 according to the Japanese classification of gastric carcinoma 15th edition), and extra-perigastric extranodal metastasis, located alongside the major vessels (#8–#12). Results Extranodal metastasis was found in 51 patients (37%), and it was more frequent in those with bulky, ≥pT3, and pStage III tumors. All patients with extra-perigastric extranodal metastasis had recurrence, resulting in a 0% 5-year overall survival rate, which was significantly worse than that of patients with perigastric extranodal metastasis (59%), or those without extranodal metastasis (84%; P  &lt; 0.001). Multivariable analysis identified the presence of extra-perigastric extranodal metastasis as an independent poor prognostic factor. Conclusions Extranodal metastasis, especially extra-perigastric extranodal metastasis, was a pivotal poor prognostic factor in node-positive gastric cancer. Recognizing extra-perigastric extranodal metastasis would help provide optimal therapeutic options to these high-risk patients.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>31312947</pmid><doi>10.1007/s00268-019-05076-x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0364-2313
ispartof World journal of surgery, 2019-10, Vol.43 (10), p.2499-2505
issn 0364-2313
1432-2323
language eng
recordid cdi_proquest_journals_2258474187
source MEDLINE; Wiley Online Library Journals Frontfile Complete; SpringerLink Journals
subjects Abdominal Surgery
Adult
Aged
Aged, 80 and over
Analysis of Variance
Blood vessels
Cancer
Cardiac Surgery
Female
Gastrectomy
Gastric cancer
General Surgery
Humans
Kaplan-Meier Estimate
Lymph nodes
Lymph Nodes - pathology
Lymphatic Metastasis
Lymphatic system
Male
Medicine
Medicine & Public Health
Metastases
Metastasis
Middle Aged
Multivariate Analysis
Neoplasm Invasiveness
Neoplasm Recurrence, Local - mortality
Nodes
Original Scientific Report
Prognosis
Recurrence
Retrospective Studies
Risk groups
Stomach Neoplasms - mortality
Stomach Neoplasms - pathology
Stomach Neoplasms - surgery
Surgery
Survival
Survival Rate
Thoracic Surgery
Treatment Outcome
Tumors
Vascular Surgery
title Extra-perigastric Extranodal Metastasis is a Significant Prognostic Factor in Node-Positive Gastric Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T09%3A31%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extra-perigastric%20Extranodal%20Metastasis%20is%20a%20Significant%20Prognostic%20Factor%20in%20Node-Positive%20Gastric%20Cancer&rft.jtitle=World%20journal%20of%20surgery&rft.au=Tonouchi,%20Akiko&rft.date=2019-10-15&rft.volume=43&rft.issue=10&rft.spage=2499&rft.epage=2505&rft.pages=2499-2505&rft.issn=0364-2313&rft.eissn=1432-2323&rft_id=info:doi/10.1007/s00268-019-05076-x&rft_dat=%3Cproquest_cross%3E2258474187%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2258474187&rft_id=info:pmid/31312947&rfr_iscdi=true